Bio-Reference Labs (BRLI)

Add to Watchlists
Create an Alert
27.26 -0.12  -0.44% NASDAQ Apr 22, 8:00PM BATS Real time Currency in USD
View Full Chart
BRLI Price Chart
View All Events

BRLI Events

Date Type Description
Mar 04 Misc Bio-Reference Laboratories Inc Q1 2014 Earning Conference Call
Mar 04 Earnings Bio-Reference Laboratories Inc Q1 2014 Earning Result. Estimate: 0.14.
Dec 19 Misc Q4 2013 Earnings Conference Call
Dec 19 Earnings Bioreference Laboratories, Inc. Provides Guidance for FY13 and Q4FY13 Anticipated Results. Estimate: 0.55.
Aug 29 Misc Q3 2013 Bio-Reference Laboratories, Inc. Earnings Conference Call
Aug 29 Earnings Q3 2013 Bio-Reference Laboratories, Inc. Earnings Results. Estimate: 0.52.
Aug 21 Misc Bioreference Laboratories, Inc. Announces Strategic Acquisition of Edge Biosystems' Service Business
Aug 13 Misc Bioreference Laboratories, Inc. Announces Strategic Acquisition
Jul 11 Misc AGM Event for Bio-Reference Laboratories Inc.
Jun 06 Misc Bioreference Laboratories Inc. 2nd Quarter Fiscal Year 2013 Earnings Conference Call
View All Performance Charts

BRLI Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Bio-Reference Labs is up 12.83% over the last year vs S&P 500 Total Return up 23.42%, Quest Diagnostics up 7.48%, and Heska up 42.00%.

Get Quote for

PDF Report for BRLI

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download BRLI Pro Report PDF

Portfolio Strategies Featuring BRLI

Did Bio-Reference Labs make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

BRLI Profile

  • Sector: Healthcare
  • Industry: Diagnostics & Research
  • Headquarters Country: United States
  • Headquarters State/Province: New Jersey
  • Incorporation Country: United States
  • Incorporation State/Province: New Jersey
  • Est. Current Fiscal Quarter End: July 31, 2014
  • Est. Current Fiscal Year End: October 31, 2014
  • Last Fiscal Quarter End: January 31, 2014
  • Last Fiscal Year End: October 31, 2013
  • NAICS: Diagnostic Imaging Centers
  • NAICS Code: 621512
  • NAICS Industry: Medical and Diagnostic Laboratories
  • NAICS Industry Code: 6215
  • NAICS Sector: Health Care and Social Assistance
  • NAICS Sector Code: 62

Bio-Reference Laboratories Inc. is the fourth largest full service laboratory in the United States and the largest independent regional laboratory in the Northeastern market, primarily a clinical testing laboratory servicing physician offices with concentrations in the focused markets of esoteric testing, molecular diagnostics, anatomical pathology, women’s health and correctional health care. BRLI operates as a national oncology laboratory as GenPath. BRLI’s innovative technology platform for sexually transmitted infections has enabled it to expand as a national laboratory in the area of Women’s Health. GeneDx, a wholly owned subsidiary, is the BRLI genetics laboratory and is typically recognized as the leading laboratory for testing of rare genetic diseases; GeneDx has now become a technology leader with GenomeDx, based on a CGH array platform and its NextGen sequence offerings that are currently offered in cardiology and will be offered in the future in other disease specific areas. The company was founded by Marc D. Grodman on December 24, 1981 and is headquartered in Elmwood Park, New Jersey.

Recent Quotes

Symbol Price Chg Chg % Market Cap
BRLI 27.26 -0.12 -0.44% 755.55M
Create Watchlist from Quotes

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

Get Started Now

Upgrade to {{}}. Start Your YCharts Membership. Start your {{}} Membership


{{ ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{}} Member? Sign in here.